![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Karger
E-ISSN: 2296-5262|39|5|266-271
ISSN: 2296-5270
Source: Oncology Research and Treatment, Vol.39, Iss.5, 2016-04, pp. : 266-271
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Management of Bone Metastases in Patients with Castration-Resistant Prostate Cancer
Urologia Internationalis, Vol. 92, Iss. 4, 2014-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Metabolic syndrome in castration‐resistant prostate cancer patients treated with abiraterone
THE PROSTATE, Vol. 75, Iss. 12, 2015-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The role of C‐reactive protein in prostate cancer
CANCER, Vol. 119, Iss. 18, 2013-09 ,pp. :